Form 4: AbbVie Executive Nicholas Donoghoe Reports Stock Transaction
SEC Form 4 Filing
Nicholas Donoghoe, EVP, CHIEF BUS/STRAT OFFICER of AbbVie Inc., reports disposition of 11,230 shares of common stock on February 28, 2025.
Summary
- On February 28, 2025, Nicholas Donoghoe, an executive at AbbVie Inc., reported a transaction involving the company's common stock.
- Donoghoe disposed of 11,230 shares of AbbVie common stock at a price of $205.02 per share.
- Following the transaction, Donoghoe directly owns 70,018 shares of AbbVie common stock.
Sentiment
Score: 5
Explanation: This is a neutral report of a stock transaction. It doesn't inherently indicate positive or negative sentiment about the company.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, as required by the SEC. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in ownership by a company executive.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Date of stock transaction |
| 03/04/2025 | Date of signature on the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.